JuHyun Bae | Cancer immunotherapy | Best Researcher Award

Best Researcher Award

JuHyun Bae
Affiliation Kyungpook National University School of Medicine
Country South Korea
Scopus ID 57225046295
Documents 15
Citations 375
h-index 10
Subject Area Cancer Immunotherapy
Event Biotechnology Scientist Awards
ORCID 0000-0002-2025-3772

JuHyun Bae
Kyungpook National University School of Medicine

JuHyun Bae, a researcher affiliated with Kyungpook National University School of Medicine, South Korea. This publication-style profile summarizes publicly available scholarly information, including research metrics, publication output, citation performance, scientific contributions, and subject expertise in Cancer Immunotherapy. The article follows a neutral, Wikipedia-inspired presentation suitable for academic recognition and professional reference.[1]

Abstract

JuHyun Bae has established a research profile focused on Cancer Immunotherapy through peer-reviewed scientific publications indexed in international bibliographic databases. Current publicly available metrics indicate 15 indexed publications, 375 citations, and an h-index of 10, reflecting consistent scientific productivity and measurable scholarly influence. This article summarizes the research profile using an objective academic format appropriate for institutional review and research recognition.[1]

Keywords

Cancer Immunotherapy, Oncology, Immunology, Precision Medicine, Translational Medicine, Biomedical Research, Scientific Publications, Citation Analysis, Biotechnology Scientist Awards, Best Researcher Award.

Introduction

Academic excellence is evaluated through a combination of research quality, publication output, citation performance, innovation, and contributions to scientific advancement. Bibliometric databases such as Scopus provide standardized indicators that assist universities, research organizations, funding agencies, and award committees in conducting objective evaluations while complementing expert peer review.[2]

Research Profile

JuHyun Bae is affiliated with Kyungpook National University School of Medicine in South Korea. The available scholarly record demonstrates active research in Cancer Immunotherapy with publications appearing in internationally indexed journals. The research portfolio contributes to ongoing investigations in biomedical science, translational medicine, and cancer-related therapeutic strategies.[1]

Research Contributions

  • Published peer-reviewed research in Cancer Immunotherapy and biomedical sciences.
  • Supported advances in translational oncology research.
  • Contributed to internationally indexed scientific literature.
  • Participated in collaborative biomedical research activities.
  • Enhanced scientific knowledge through evidence-based medical research.

Publications

The researcher’s Scopus profile records 15 indexed publications. These scholarly works contribute to Cancer Immunotherapy and related biomedical disciplines. Many scientific articles include Digital Object Identifiers (DOIs), providing permanent identification and reliable access to published research while supporting accurate scholarly citation.[3]

  • Peer-reviewed journal publications indexed in Scopus.
  • Research articles in oncology, immunology, and translational medicine.

Research Impact

Bibliometric indicators report 15 indexed documents, 375 citations, and an h-index of 10. These metrics demonstrate measurable scholarly visibility and research influence within the biomedical sciences. Quantitative indicators should be interpreted together with publication quality, originality, scientific rigor, collaborative engagement, and broader contributions to medical research.[1]

Award Suitability

Based on publicly available academic indicators, JuHyun Bae demonstrates characteristics commonly considered during evaluations for recognition programs such as the Biotechnology Scientist Awards. Consideration may include publication quality, research significance, citation influence, innovation, ethical research conduct, collaborative achievements, and contributions to Cancer Immunotherapy. Final award decisions remain subject to independent peer review and committee evaluation.[2]

Conclusion

This academic profile presents a structured overview of JuHyun Bae’s scholarly achievements using publicly available bibliographic information. The article follows a neutral encyclopedia-style presentation that emphasizes research productivity, publication performance, scientific impact, and professional contributions, making it suitable for academic reference, institutional evaluation, and research recognition.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: JuHyun Bae, Author ID 57225046295. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57225046295
  2. Systematic discovery of immunomodulatory plant-derived nanoparticles reveals RNA-mediated macrophage reprogramming.
    https://www.sciencedirect.com/science/article/pii/S2452199X26003701?via%3Dihub
  3. Determination of extracellular vesicle size and surface charge density via precise measurements of Brownian motion, electrophoretic velocity, and applied electric field in a single platform.
    https://www.sciencedirect.com/science/article/abs/pii/S0925400526001486?via%3Dihub

Edmund Waller | Immuno-Oncology | Best Researcher Award

Prof. Dr. Edmund Waller | Immuno-Oncology |  Best Researcher Award

Lead Scientist at Cambium Oncology | United States

Prof. Dr. Edmund Waller demonstrates exceptional research excellence and global scientific impact, making him highly suitable for the Best Researcher Award. His contributions to hematology, oncology, and immunotherapy have significantly advanced understanding and clinical applications in stem cell transplantation and cancer treatment. With an outstanding Scopus profile reflecting 22,833 citations across 19,098 documents, 388 publications, and an h-index of 75, his work shows both high productivity and sustained scholarly influence. His research is widely recognized for its translational relevance, bridging laboratory discoveries with clinical outcomes, particularly in immune regulation and anti-tumor therapies. The consistency of high-impact publications and extensive citation record highlights his leadership in the field and the global adoption of his findings. Overall, his strong bibliometric indicators, innovative research contributions, and enduring academic influence clearly position him as a distinguished and deserving candidate for the Best Researcher Award.

Citation Metrics (Scopus)

23000

10000

1000

500

0

Citations
22,833

Documents
388

h-index
75

Citations

Documents

h-index

Featured Publications


Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma
SJ Schuster, MR Bishop, CS Tam, EK Waller, et al.
New England Journal of Medicine, 2019
Citations: 4518


A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning
S Miraglia, W Godfrey, AH Yin, et al.
Blood (American Society of Hematology), 1997
Citations: 1393


Peripheral-blood stem cells versus bone marrow from unrelated donors
C Anasetti, BR Logan, SJ Lee, EK Waller, et al.
New England Journal of Medicine, 2012
Citations: 1130


Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
D Miklos, CS Cutler, M Arora, EK Waller, et al.
Blood (American Society of Hematology), 2017
Citations: 592